MA
MAIA Biotechnology, Inc.
MAIA · AMEX
$1.18 +0.85% (+$0.01)
1M -9.85%
Market Cap $71.1M
P/E Ratio -
Div. Yield -
ROE 211.15%
Bulios Fair Price
$1.68
42.4% upside
Current Price
$1.18
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MAIA is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
59 /100
Fair P/B 3.44x
EV/FFO N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 34.64%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 211.15%
ROA 95.06%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 4.51x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
49 /100
Moderate EPS volatility 11.18%
Profitable years 0
Beta 0.26x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MAIA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Vlad Vitoc
Employees
13
Headquarters
Chicago
Upcoming events
06 NOV
Earnings
Upcoming earnings report